Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

118,329 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and validation of a preoperative CT-based radiomic nomogram to predict pathology invasiveness in patients with a solitary pulmonary nodule: a machine learning approach, multicenter, diagnostic study.
Huang L, Lin W, Xie D, Yu Y, Cao H, Liao G, Wu S, Yao L, Wang Z, Wang M, Wang S, Wang G, Zhang D, Yao S, He Z, Cho WC, Chen D, Zhang Z, Li W, Qiao G, Chan LW, Zhou H. Huang L, et al. Among authors: wang g, wang z, wang m, wang s. Eur Radiol. 2022 Mar;32(3):1983-1996. doi: 10.1007/s00330-021-08268-z. Epub 2021 Oct 16. Eur Radiol. 2022. PMID: 34654966 Free PMC article. Clinical Trial.
PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
Liu J, Chen H, Qiao G, Zhang JT, Zhang S, Zhu C, Chen Y, Tang J, Li W, Wang S, Tian H, Chen Z, Ma D, Tian J, Wu YL. Liu J, et al. Among authors: wang s. Cancer Immunol Immunother. 2023 Apr;72(4):881-893. doi: 10.1007/s00262-022-03288-0. Epub 2022 Sep 19. Cancer Immunol Immunother. 2023. PMID: 36121452 Free PMC article.
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB-IV NSCLC (LCDigital-IO Study): a multicenter retrospective study.
Wu S, Zhan W, Liu L, Xie D, Yao L, Yao H, Liao G, Huang L, Zhou Y, You P, Huang Z, Li Q, Xu B, Wang S, Wang G, Zhang DK, Qiao G, Chan LW, Lanuti M, Zhou H. Wu S, et al. Among authors: wang g, wang s. J Immunother Cancer. 2023 Oct;11(10):e007369. doi: 10.1136/jitc-2023-007369. J Immunother Cancer. 2023. PMID: 37865396 Free PMC article.
118,329 results
You have reached the last available page of results. Please see the User Guide for more information.